Clinical trials
Recruiting trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
621 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 13 |
| 2020 | 14 |
| 2021 | 23 |
| 2022 | 33 |
| 2023 | 69 |
| 2024 | 115 |
| 2025 | 196 |
| 2026 | 133 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 621 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 49 |
| Tata Memorial Centre | 36 |
| Asian Institute of Gastroenterology, India | 29 |
| Postgraduate Institute of Dental Sciences Rohtak | 26 |
| Institute of Liver and Biliary Sciences, India | 23 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 21 |
| Eli Lilly and Company | 20 |
| Pfizer | 19 |
| Bristol-Myers Squibb | 17 |
| Tata Memorial Hospital | 17 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 21 |
| Diabetes Mellitus, Type 2 | 20 |
| Breast Neoplasms | 16 |
| Heart Failure | 15 |
| Obesity | 14 |
| Uterine Cervical Neoplasms | 14 |
| Overweight | 12 |
| Renal Insufficiency, Chronic | 12 |
| Fibrosis | 11 |
| Colitis, Ulcerative | 10 |
Trials
Showing 1 to 25 of 621. Each trial links to its page on Pharma Observatory.
521 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.